<!DOCTYPE html>
<!--[if (gt IE 9)|!(IE)]> <!--> <html lang="en" class="no-js has-comments blog-dealbook section-business"  itemscope xmlns:og="//opengraphprotocol.org/schema/"> <!--<![endif]-->
<!--[if IE 9]> <html lang="en" class="no-js ie9 lt-ie10 has-comments blog-dealbook section-business" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="no-js ie8 lt-ie10 lt-ie9 has-comments blog-dealbook section-business" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if (lt IE 8)]> <html lang="en" class="no-js lt-ie10 lt-ie9 lt-ie8 has-comments blog-dealbook section-business" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>
		<meta name="channels" content="NytNow" />
<meta name="communityAssetLabels" content="NYT_Blogs" />
<meta name="communityAssetTaxonomy" content="blogs/dealbook/Mega-Mergers Popular Again on Wall Street ( 20141117 )" />
<meta name="communityAssetURL" content="https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/" />
<meta name="PT" content="Blogs" />
<meta name="PST" content="Blog Post" />
<meta name="sourceApp" content="blogs" />
<meta itemprop="identifier" name="blogpostid" content="100000003240711"><meta name="author" content="David Gelles" />
<meta name="CLMST" content="David Gelles" />
<meta name="byl" content="David Gelles" />
<meta name="article:author" content="//topics.nytimes.com/top/reference/timestopics/people/g/david_gelles/index.html" /><meta name="GBLC" content="Energy;Healthcare;Mergers &amp; Acquisitions;Top Headline 1;Top Headline 2">
<meta name="PUV" content="normal" />
<meta property="article:published_time" itemprop="datePublished" content="1416277794" />
<meta name="PUD" content="20141117" />
<meta name="pdate" content="20141117" />
<meta name="ptime" content="20141117212954" />
<meta name="utime" content="20141118175928" />
<meta property="article:modified_time" itemprop="dateModified" content="2014-11-18T17:59:28-05:00" />
<meta name="DISPLAYDATE" content="November 17, 2014" />
<meta name="dat" content="November 17, 2014" />
<meta itemprop="articleSection" property="article:section" content="Business Day" />
<meta name="CG" content="Business Day" />
<meta name="SCG" content="Dealbook" />
<meta name="BN" content="dealbook" />
<meta name="robots" content="noodp">
<meta name="per" content="Ackman, William A">
<meta name="des" content="Antitrust Laws and Competition Issues;Banking and Financial Institutions;Drugs (Pharmaceuticals);Mergers, Acquisitions and Divestitures;Regulation and Deregulation of Industry">
<meta name="org" content="AbbVie Inc;Actavis PLC;Allergan Inc;Baker Hughes Inc;Halliburton Company;Pershing Square Capital Management;Valeant Pharmaceuticals International Inc">
<meta name="ticker" content="AbbVie Inc|ABBV|NYSE;Actavis PLC|ACT|NYSE;Allergan Inc|AGN|NYSE;Baker Hughes Inc|BHI|NYSE;Halliburton Company|HAL|NYSE;Valeant Pharmaceuticals International Inc|VRX|NYSE" />
<meta property="article:tag" content="Ackman William A" />
<meta property="article:tag" content="Antitrust Laws and Competition Issues" />
<meta property="article:tag" content="Banking and Financial Institutions" />
<meta property="article:tag" content="Drugs (Pharmaceuticals)" />
<meta property="article:tag" content="Mergers Acquisitions and Divestitures" />
<meta property="article:tag" content="Regulation and Deregulation of Industry" />
<meta property="article:tag" content="AbbVie Inc" />
<meta property="article:tag" content="Actavis PLC" />
<meta property="article:tag" content="Allergan Inc" />
<meta property="article:tag" content="Baker Hughes Inc" />
<meta property="article:tag" content="Halliburton Company" />
<meta property="article:tag" content="Pershing Square Capital Management" />
<meta property="article:tag" content="Valeant Pharmaceuticals International Inc" />
<meta property="article:tag" content="Energy" />
<meta property="article:tag" content="Healthcare" />
<meta property="article:tag" content="Mergers &amp; Acquisitions" />
<meta property="article:tag" content="Top Headline 1" />
<meta property="article:tag" content="Top Headline 2" />
<meta name="keywords" content="Ackman William A,Antitrust Laws and Competition Issues,Banking and Financial Institutions,Drugs (Pharmaceuticals),Mergers Acquisitions and Divestitures,Regulation and Deregulation of Industry,AbbVie Inc,Actavis PLC,Allergan Inc,Baker Hughes Inc,Halliburton Company,Pershing Square Capital Management,Valeant Pharmaceuticals International Inc,Energy,Healthcare,Mergers &amp; Acquisitions,Top Headline 1,Top Headline 2" />
<meta name="news_keywords" content="Banking and Finance,Competition law,Mergers and Acquistions,Pershing Square Capital Management,Pharmaceuticals,Regulation and Deregulation,William A Ackman" />
<link rel="alternate" type="application/json+oembed" href="https://www.nytimes.com/svc/oembed/json/?url=https%3A%2F%2Fdealbook.nytimes.com%2F2014%2F11%2F17%2Fmega-mergers-popular-again-on-wall-street%2F" title="Mega-Mergers Popular Again on Wall Street" />
<meta name="description" content="A pair of deals announced on Monday, worth $100 billion, brought the year&#8217;s total for American companies to $1.5 trillion, the highest since 2000." />
<meta name="hdl_p" content="Mega-Mergers Popular Again on Wall Street" />
<meta name="hdl" content="Mega-Mergers Popular Again on Wall Street" />
<meta property="og:title" content="Mega-Mergers Popular Again on Wall Street" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/" />
<meta property="og:site_name" content="DealBook" />
<meta property="og:description" content="A pair of deals announced on Monday, worth $100 billion, brought the year&#8217;s total for American companies to $1.5 trillion, the highest since 2000." />
<meta property="og:image" content="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-superJumbo-v2.png"/>
<meta name="thumbnail_150" content="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-thumbLarge-v3.png"/>
<meta name="twitter:card" value="summary"><meta name="twitter:title" content="Mega-Mergers Popular Again on Wall Street" />
<meta name="twitter:url" content="https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/" />
<meta name="twitter:description" content="A pair of deals announced on Monday, worth $100 billion, brought the year&#8217;s total for American companies to $1.5 trillion, the highest since 2000." />
<meta name="twitter:image" content="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-thumbLarge-v3.png"/>
<meta itemprop="thumbnailUrl" content="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-thumbLarge-v3.png" name="thumbnail" />
<meta name="twitter:site" content="@dealbook">
<link rel='prev' title='Ackman Has Luck of a Loser, to the Tune of $2.2 Billion' href='https://dealbook.nytimes.com/2014/11/17/the-luck-of-a-loser-to-the-tune-of-2-2-billion/' />
<link rel='next' title='Morning Agenda: Return of the Mega-Merger' href='https://dealbook.nytimes.com/2014/11/18/morning-agenda-return-of-the-mega-merger/' />
<link rel='canonical' href='https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/' />
<link rel='shortlink' href='//nyti.ms/1ETNbJl' />
<link rel='https://github.com/WP-API/WP-API' href='https://dealbook.nytimes.com/json' />
<meta name="adxPage" content="blog.nytimes.com/dealbook/post" />
<link rel="alternate" type="application/rss+xml" title="RSS 2.0" href="https://dealbook.nytimes.com/feed/" />
<meta property="article:collection" content="https://static01.nyt.com/services/json/sectionfronts/business/index.jsonp" />
<link rel="alternate" href="//mobile.nytimes.comdealbook/2014/11/17/mega-mergers-popular-again-on-wall-street/" />
<meta name="dfp-ad-unit-path" content="businessday/dealbook" />			<title>Mega-Mergers Popular Again on Wall Street - The New York Times</title>
            <!--[if (gt IE 9)|!(IE)]> <!-->
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles.css" />
<!--<![endif]-->
<!--[if lte IE 9]>
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-ie.css" />
<![endif]-->
<link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/dealbook.css" />
<link rel="stylesheet" type="text/css" media="print" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-print.css" />
<script>
var NYT = NYT || {}, NYTD = NYTD || {};
</script>
                        	<script src="https://int.nyt.com/assets/blogs/latest/js/blogs/layout.js"></script>
	<script type="text/javascript">var googletag=googletag||{};googletag.cmd=googletag.cmd||[],function(){var t=document.createElement("script");t.async=!0,t.type="text/javascript";var e="https:"==document.location.protocol;t.src=(e?"https:":"http:")+"//www.googletagservices.com/tag/js/gpt.js";var o=document.getElementsByTagName("script")[0];if (!/NYT-T=out/.test(document.cookie)) {o.parentNode.insertBefore(t,o)}}();</script>
<script id="magnum-feature-flags" type="application/json">["limitFabrikSave","facebookOauthButton","videoVHSCover","videoVHSShareTools","videoVHSEmbeddedOnly","removeInternationalEdition","piiBlockDFP","indexAsHeaderBidder","caslOpt"]</script>
<script>
var require = {
    baseUrl: 'https://int.nyt.com/assets/',
    waitSeconds: 20,
    paths: {
        'foundation': 'blogs/latest/js/foundation',
        'shared': 'blogs/latest/js/shared',
        'blogs': 'blogs/latest/js/blogs',
        'auth/mtr': 'https://static01.nyt.com/js/mtr',
        'auth/growl': 'https://static01.nyt.com/js/auth/growl/default',
        'vhs': 'https://static01.nyt.com/video/vhs/build/vhs-2.x.min'
    }
};
</script>
<!--[if (gte IE 9)|!(IE)]> <!-->
<script data-main="foundation/main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script>
require.map = { '*': { 'foundation/main': 'foundation/legacy_main' } };
</script>
<script data-main="foundation/legacy_main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<![endif]-->
<script>
require(['foundation/main'], function () {
    require(['auth/mtr']);
});
</script>
<!--esi
<script id="user-info-data" type="application/json">
<esi:include src="/svc/web-products/userinfo-v3.json" />
</script>
-->
    	</head><body class="single single-post postid-637831 blog-universal nyt-blog-dealbook" id="" data-env="production" data-region="ewr1">
	<div id="shell" class="shell">
			<header id="masthead" class="masthead masthead-theme-standard" role="banner">
    <div class="container">
        <div class="quick-navigation button-group">
            <button class="button sections-button"><i class="icon sprite-icon"></i><span class="button-text">Sections</span></button>
            <button class="button home-button" data-href="https://www.nytimes.com/" title="Go to the home page to see the latest top stories."><i class="icon sprite-icon"></i>
                <span class="button-text">Home</span>
            </button>
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <a class="button skip-button skip-to-content visually-hidden focusable" href="#main">Skip to content</a>
                                </div><!-- close button-group -->
        <div class="branding">
            <h2 class="branding-heading">
                <a id="branding-heading-link" href="https://www.nytimes.com/">
                    <span class="visually-hidden">The New York Times</span>
                </a>
            </h2>
            <script>window.magnum.writeLogo('small', 'https://int.nyt.com/assets/blogs/latest/images/foundation/logos/', 'Business Day', 'masthead-theme-standard', 'standard', 'branding-heading-link', 'blogs');</script>
        </div><!-- close branding -->
        <div class="story-meta">
    <h6 class="kicker">
        <span class="kicker-label">
			            <a href="https://dealbook.nytimes.com">
                DealBook            </a>
			        </span>

                <span class="pipe">|</span>
        Mega-Mergers Popular Again on Wall Street        
    </h6>
</div><!-- close story-meta -->


        <div class="user-tools">
            <div id="Bar1" class="ad bar1-ad nocontent robots-nocontent"></div>
            <div id="sharetools-masthead" class="sharetools theme-classic"
	 data-shares="email,facebook,twitter,show-all|More"
	 data-url="https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/"
	 data-title="Mega-Mergers Popular Again on Wall Street"
	 data-description="&lt;span class=&quot;excerpt-inner&quot;&gt;A pair of deals announced on Monday, worth $100 billion, brought the yearâs total for American companies to $1.5 trillion, the highest since 2000. &lt;/span&gt;&lt;a href=&quot;https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
	data-publish-date="November 17, 2014 9:29 pm">
<div class="ad sharetools-inline-article-ad hidden"></div>
</div><!-- close shareTools -->
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <div class="user-tools-button-group button-group">
                <button class="button subscribe-button hidden" data-href="https://www.nytimes.com/subscriptions/Multiproduct/lp3004.html?campaignId=4XUYF">Subscribe Now</button>
                <button class="button login-button login-modal-trigger hidden">Log In</button>
                <button class="button comments-button  button-masthead" data-skip-to-para-id="">
</button>
                                <button class="button notifications-button hidden"><i class="icon sprite-icon"></i><span class="button-text">0</span></button>
                <button class="button user-settings-button"><i class="icon sprite-icon"></i><span class="button-text">Settings</span></button>
            </div><!-- close user-tools-button-group -->
        </div><!-- close user-tools -->
    </div><!-- close container -->
    <div class="search-flyout-panel flyout-panel">
    <button class="button close-button" type="button"><i class="icon"></i><span class="visually-hidden">Close search</span></button>
    <nav class="search-form-control form-control layout-horizontal">
    <h2 class="visually-hidden">Site Search Navigation</h2>
    <form class="search-form" role="search">
        <div class="control">
            <div class="label-container visually-hidden">
                                <label for="search-input">Search NYTimes.com</label>
                            </div>
            <div class="field-container">
                                <input id="search-input" name="search-input" type="text" class="search-input text" autocomplete="off" placeholder="Search NYTimes.com" />
                
                <button type="button" class="button clear-button" tabindex="-1" aria-describedby="clear-search-input"><i class="icon"></i><span id="clear-search-input" class="visually-hidden">Clear this text input</span></button>
                <div class="auto-suggest" style="display: none;">
                    <ol></ol>
                </div>
                <button class="button submit-button" type="submit">Go</button>
            </div>
        </div><!-- close control -->
    </form>
</nav>


</div><!-- close flyout-panel -->
    <div id="notification-modals" class="notification-modals"></div>
</header>
					<nav id="ribbon" class="ribbon ribbon-start nocontent robots-nocontent" aria-hidden="true">
    <div class="nocontent robots-nocontent">
        <ol class="ribbon-menu">
            <li class="collection ribbon-loader">
                <div class="loader "><span class="visually-hidden">Loading...</span></div>
            </li>
        </ol>
        <div class="ribbon-navigation-container">
            <nav class="ribbon-navigation next">
                <span class="visually-hidden">See next articles</span>
                <div class="arrow arrow-right">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
            <nav class="ribbon-navigation previous">
                <span class="visually-hidden">See previous articles</span>
                <div class="arrow arrow-left">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
        </div>
    </div><!-- close nocontent -->
</nav>
						<nav id="navigation" class="navigation">
    <h2 class="visually-hidden">Site Navigation</h2>
</nav><!-- close navigation -->

<nav id="mobile-navigation" class="mobile-navigation hidden">
    <h2 class="visually-hidden">Site Mobile Navigation</h2>
</nav><!-- close mobile-navigation -->

    <div id="navigation-edge" class="navigation-edge"></div>
				<main id="main" class="main" role="main">
				<div id="TopAd" class="ad top-ad"></div>
				<div id="mobilebanner" class="ad mobilebanner"></div>
								<div id="story" class="story theme-main">
		<div id="dealbook" class="spanAC blog">
			<header id="blogs-masthead" class="wrap">
	<div class="ad sponsortile-ad hidden nocontent robots-nocontent">
		<div class="caption">Supported by</div>
		<div id="sponsortile" class="ad sponsortile-ad-creative"></div>
	</div>
		<div class="element1">
	<div id="logo" ><a href="https://dealbook.nytimes.com/?module=BlogMain&action=Click&region=Header&pgtype=Blogs&version=Blog Post&contentCollection=Business Day" title="Go to DealBook Home"><img src="https://static01.nyt.com/images/blogs_v5/dealbook/dealbook_post.png" alt="DealBook - A Financial News Service of The New York Times"/></a></div>    </div>
    <div class="element2">
    <div class="inlineSearchControl">
	<form method="get" id="searchform" action="https://dealbook.nytimes.com/">
		<input type="text" value="" name="s" id="s" class="text" placeholder="Search DealBook">
		<button type="submit" class="searchsubmit">Search</button>
	</form>
</div>	</div>
	<div class="clear"></div>
		<div id="topic-nav">
		<ul>
			<li class="first"><a href="https://dealbook.nytimes.com/category/main-topics/mergers-acquisitions/">Mergers &amp; Acquisitions</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/investment-banking/">Investment Banking</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/private-equity/">Private Equity</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/hedge-funds/">Hedge Funds</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/ipoofferings/">I.P.O./Offerings</a></li>
			<li><a href="https://dealbook.nytimes.com/category/main-topics/venture-capital/">Venture Capital</a></li>
			<li class="last"><a href="https://dealbook.nytimes.com/category/main-topics/legal/">Legal/Regulatory</a></li>
		</ul>
	</div>
		</header>
	<div class="a-column " id="a-col">
	<div id="content" class="hfeed">
	<article class="post-637831 post type-post status-publish hentry category-energy-by-industry-2 category-healthcare category-mergers-acquisitions tag-abbvie-inc tag-ackman-william-a tag-actavis-plc tag-allergan-inc tag-antitrust-laws-and-competition-issues tag-baker-hughes-inc tag-banking-and-financial-institutions tag-drugs-pharmaceuticals tag-halliburton-company tag-mergers-acquisitions-and-divestitures tag-pershing-square-capital-management tag-regulation-and-deregulation-of-industry tag-valeant-pharmaceuticals-international-inc per-ackman-william-a des-antitrust-laws-and-competition-issues des-banking-and-financial-institutions des-drugs-pharmaceuticals des-mergers-acquisitions-and-divestitures des-regulation-and-deregulation-of-industry org-abbvie-inc org-actavis-plc org-allergan-inc org-baker-hughes-inc org-halliburton-company org-pershing-square-capital-management org-valeant-pharmaceuticals-international-inc news_keywords-banking-and-finance news_keywords-competition-law news_keywords-mergers-and-acquistions news_keywords-pershing-square-capital-management news_keywords-pharmaceuticals-2 news_keywords-regulation-and-deregulation news_keywords-william-a-ackman-2" id="post-637831">
	<header class="postHeader">
				<div class="postKicker">
					</div>
				<h1 itemprop="headline" class="entry-title">Mega-Mergers Popular Again on Wall Street</h1>
		<div class="story-meta-footer">
			<address class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
				By David Gelles			</address>
			<!-- date published --><time class="dateline " datetime="2014-11-18T02:29:54+00:00" itemprop="datePublished">November 17, 2014 9:29 pm</time>
			<!-- date updated --><span class="visually-hidden updated">November 17, 2014 9:29 pm</span><button class="button comments-button  theme-kicker" data-skip-to-para-id="">
</button>
		</div>
			</header>
		<div class="entry-content">
	<div class="w592"><figure class="media photo promo" itemprop="associatedMedia" itemscope="" itemid="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-tmagArticle-v2.png" itemtype="//schema.org/ImageObject" role="group"><span class="visually-hidden">Photo</span><div class="image"><img itemprop="url" itemid="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-tmagArticle-v2.png" src="https://static01.nyt.com/images/2014/11/18/business/18mergers-graphic/18mergers-graphic-tmagArticle-v2.png" id="100000003240726" width="592" height="381" alt=""   /><meta itemprop="height" content="381"><meta itemprop="width" content="592"></div><figcaption class="caption" itemprop="description"><span class="caption-text"></span><span class="credit" itemprop="copyrightHolder"><span class="visually-hidden">Credit</span> </span></figcaption></figure></div>
<div id="sharetools-story" class="sharetools theme-classic sharetools-story" data-shares="email|Email,facebook|Share,twitter|Tweet,save|Save,show-all|More,ad" data-url="https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/" data-title="Mega-Mergers Popular Again on Wall Street" data-description="A pair of deals announced on Monday, worth $100 billion, brought the yearâs total for American companies to $1.5 trillion, the highest since 2000. ">
				<div class="ad sharetools-inline-article-ad"></div>
				<div id="MiddleLeft" class="ad middle-left-ad nocontent robots-nocontent"></div>
				</div><div class="entry entry-related">
<h4>Related Links</h4>
<div class="entry-related">
<ul>
<li><a href="//dealbook.nytimes.com/2014/11/17/allergan-agrees-to-be-sold-to-actavis/">Deal Thwarted by a Company Newly Irish</a> | <a href="//www.nytimes.com/interactive/2014/11/18/business/dealbook/18allergan-timeline.html">Timeline</a></li>
<li><a href="//dealbook.nytimes.com/2014/11/17/the-luck-of-a-loser-to-the-tune-of-2-2-billion/">Sorkin:  The Luck of a Loser, to the Tune of $2.2 Billion</a></li>
<li><a href="//dealbook.nytimes.com/2014/11/17/halliburton-to-buy-baker-hughes-for-34-billion/">Oil Services Giants Agree to Friendly Merger</a></li>
</ul></div>
</p></div>
<p class="story-body-text" itemprop="articleBody">Stocks are surging, corporate executives are ambitious and debt is cheap. The result is one of the biggest booms ever in mergers and acquisitions.</p>
<p class="story-body-text" itemprop="articleBody">Mergers worth $100 billion, made on Monday, put Wall Street on pace for a year of deal-making rivaling those during the dot-com bubble and the <a href="//dealbook.nytimes.com/category/main-topics/private-equity/?inline=nyt-classifier" class="tickerized" title="More articles about private equity.">private equity</a> upsurge just before the financial crisis.</p>
<p class="story-body-text" itemprop="articleBody">The announcement of two more mega-deals â the <a href="//dealbook.nytimes.com/2014/11/17/allergan-agrees-to-be-sold-to-actavis/" title="Deal Thwarted by a Company Newly Irish">$66 billion acquisition of the Botox-maker</a> <a href="//dealbook.on.nytimes.com/public/overview?symbol=AGN&#038;inline=nyt-org" class="tickerized" title="More information about Allergan Inc">Allergan</a> by <a href="//dealbook.on.nytimes.com/public/overview?symbol=ACT&#038;inline=nyt-org" class="tickerized" title="More information about Actavis PLC.">Actavis</a> , and the <a href="//dealbook.nytimes.com/2014/11/17/halliburton-to-buy-baker-hughes-for-34-billion/" title="Oil Services Giants Agree to Friendly Merger">$34.6 billion takeover of the oil field services firm</a> <a href="//dealbook.on.nytimes.com/public/overview?symbol=BHI&#038;inline=nyt-org" class="tickerized" title="More information about Baker Hughes Inc">Baker Hughes</a> by a bigger rival, <a href="//dealbook.on.nytimes.com/public/overview?symbol=HAL&#038;inline=nyt-org" class="tickerized" title="More information about Halliburton Company">Halliburton</a> â made Monday a symbolic tipping point. </p>
<p class="story-body-text" itemprop="articleBody">With those transactions on the books, about $1.5 trillion in deals targeting American companies have been announced this year, the most since 2000, according to <a href="//dealbook.on.nytimes.com/public/overview?symbol=TRI&#038;inline=nyt-org" class="tickerized" title="More information about Thomson Reuters Corporation">Thomson Reuters</a>, the financial information company.</p>
<p class="story-body-text" itemprop="articleBody">Five years after the end of the financial crisis that reshaped the economy, it appears that big companies are finally willing to make big bets again, especially in the health care, technology and media industries. The conditions are ideal, with borrowing costs low and share prices rising. And chief executives are no longer worried about a double-dip recession or another eurozone crisis. Instead, they are betting on growth in the years ahead.</p>
<p class="story-body-text" itemprop="articleBody">âThe fact that weâre getting all these deals suggests that C.E.O.s are feeling pretty good about things,â said Mark Zandi, chief economist at <a href="//dealbook.on.nytimes.com/public/overview?symbol=MCO&#038;inline=nyt-org" class="tickerized" title="More information about Moody's Corporation">Moodyâs</a> Analytics. âIt reflects the economy, and it also portends better times ahead. Deals donât get done unless people feel pretty good about the future.â</p>
<div class="w480"><figure class="media photo promo" itemprop="" itemscope="" itemid="https://static01.nyt.com/images/2014/11/18/business/Merger/Merger-blog480.jpg" itemtype="//schema.org/ImageObject" role="group"><span class="visually-hidden">Photo</span><div class="image"><img itemprop="url" itemid="https://static01.nyt.com/images/2014/11/18/business/Merger/Merger-blog480.jpg" src="https://static01.nyt.com/images/2014/11/18/business/Merger/Merger-blog480.jpg" id="100000003240240" width="480" height="282" alt="David Pyott, chief executive of Allergan, left, and Brent Saunders, head of Actavis, discussing their deal on the floor of the New York Stock Exchange."   /><meta itemprop="height" content="282"><meta itemprop="width" content="480"></div><figcaption class="caption" itemprop="description"><span class="caption-text">David Pyott, chief executive of Allergan, left, and Brent Saunders, head of Actavis, discussing their deal on the floor of the New York Stock Exchange.</span><span class="credit" itemprop="copyrightHolder"><span class="visually-hidden">Credit</span> Brendan McDermid/Reuters</span></figcaption></figure></div>
<p class="story-body-text" itemprop="articleBody">Global deal-making in 2014 has topped the $3 trillion mark in a year for only the fifth time and is up 50 percent from the same time a year ago, while acquisitions targeting American companies are up 65 percent, according to Thomson Reuters.</p>
<p class="story-body-text" itemprop="articleBody">Yet there are some dark corners in the dazzling successes of Wall Streetâs deal makers. Even as companies spend on mergers and acquisitions, they are not spending in other areas. Wage growth remains sluggish, and hiring is growing only modestly.</p>
<p class="story-body-text" itemprop="articleBody">Moreover, whether or not mergers and acquisitions are even a positive for the economy â and for the companies striking them â remains a subject of debate. Mergers also often create redundancies, which can lead to job cuts.</p>
<p class="story-body-text" itemprop="articleBody">âThere is some evidence that deals may actually be detrimental to the economy, particularly these big bursts,â said Tara M. Sinclair, an associate professor of economics at <a href="//topics.nytimes.com/top/reference/timestopics/organizations/g/george_washington_university/index.html?inline=nyt-org" class="tickerized" title="More articles about George Washington University">George Washington University</a>. âEconomists are pretty divided as to whether theyâre a good thing or a bad thing.â</p>
<p class="story-body-text" itemprop="articleBody">Regulatory hurdles also threaten to complicate some of the most audacious mergers. <a href="//dealbook.on.nytimes.com/public/overview?symbol=CMCSA&#038;inline=nyt-org" class="tickerized" title="More information about Comcast Corporation">Comcast</a>âs proposed $45 billion takeover of <a href="//dealbook.on.nytimes.com/public/overview?symbol=TWC&#038;inline=nyt-org" class="tickerized" title="More information about Time Warner Cable Inc">Time Warner Cable</a> remains under scrutiny by antitrust officials in Washington, who are examining whether the combination will hurt consumers.</p>
<p class="story-body-text" itemprop="articleBody">In another instance, <a href="//dealbook.on.nytimes.com/public/overview?symbol=SFTBF&#038;inline=nyt-org" class="tickerized" title="More information about SOFTBANK Corporation">SoftBank</a>, the Japanese firm that owns the wireless provider <a href="//dealbook.on.nytimes.com/public/overview?symbol=S&#038;inline=nyt-org" class="tickerized" title="More information about Sprint Nextel Corporation">Sprint</a>, backed away from a planned acquisition of <a href="//dealbook.on.nytimes.com/public/overview?symbol=TMUS&#038;inline=nyt-org" class="tickerized" title="More information about T-Mobile Us Inc.">T-Mobile USA</a> after it became convinced that the deal would not pass muster with antitrust regulators. And Halliburtonâs deal for Baker Hughes could also draw a close look.</p>
<p class="story-body-text" itemprop="articleBody">âThe thing Iâve been anxious about all year is that some regulatory activity blocks one of these deals, and then the M.&#038;A. recovery slows down,â said Gregg R. Lemkau, global co-head of mergers and acquisitions at <a href="//dealbook.on.nytimes.com/public/overview?symbol=GS&#038;inline=nyt-org" class="tickerized" title="More information about Goldman Sachs Group Inc">Goldman Sachs</a>. âNo C.E.O. wants to do a âbet the company dealâ and not get it done, and regulatory scrutiny could be a roadblock to this continuing.â</p>
<p class="story-body-text" itemprop="articleBody">Already, the Obama administration effectively scuttled one mega-deal. After a flurry of so-called inversions, in which American companies bought overseas competitors and moved their headquarters abroad to reduce their tax bills, the <a href="//topics.nytimes.com/top/reference/timestopics/organizations/t/treasury_department/index.html?inline=nyt-org" class="tickerized" title="More articles about the U.S. Treasury Department.">Treasury</a> Department in September announced rules targeting the transactions.</p>
<p class="story-body-text" itemprop="articleBody">Weeks later, <a href="//dealbook.on.nytimes.com/public/overview?symbol=ABBV&#038;inline=nyt-org" class="tickerized" title="More information about AbbVie Inc.">AbbVie</a>, a drug maker based near Chicago, walked away from a $54 billion agreement to acquire its Irish rival Shire. Other inversions in the works were put off, and few such deals have been announced in recent months.</p>
<p class="story-body-text" itemprop="articleBody">Nonetheless, the size and variety of deals being tried reflect a new sense of ambition among many of the worldâs biggest companies.</p>
<p class="story-body-text" itemprop="articleBody">âThere is a frenzy for M.&#038;A. that is driven in part by the low cost and accessibility of capital, and the need for consolidation in many industries,&#8221; said Brent Saunders, chief executive of Actavis, which on Monday struck the biggest deal of the year.</p>
<p class="story-body-text" itemprop="articleBody">Many of the larger deals have been driven by sweeping changes that are shaking up entire industries. Drug makers like <a href="//dealbook.on.nytimes.com/public/overview?symbol=PFE&#038;inline=nyt-org" class="tickerized" title="More information about Pfizer Inc">Pfizer</a> and Actavis are on the hunt for new products to fill in gaps in their offerings. The health care industry is responsible for much of the surge in deal-making this year, producing $423.6 billion in announced deals, or nearly double the next-busiest year.</p>
<p class="story-body-text" itemprop="articleBody">Telecommunications firms sought to bolster their footprints across the country and gain more negotiating power with content providers. Comcastâs agreement to buy Time Warner Cable was followed by <a href="//dealbook.on.nytimes.com/public/overview?symbol=T&#038;inline=nyt-org" class="tickerized" title="More information about AT&#038;T Inc">AT&#038;T</a>âs agreement to buy DirecTV for $48.5 billion. Even media giants like 21st Century Fox, run by <a href="//topics.nytimes.com/top/reference/timestopics/people/m/rupert_murdoch/index.html?inline=nyt-per" class="tickerized" title="More articles about Rupert Murdoch.">Rupert Murdoch</a>, looked to deal making, in part to give them more clout to use against distributors.</p>
<p class="story-body-text" itemprop="articleBody">And companies like social networks and cigarette makers also got involved. <a href="//dealbook.on.nytimes.com/public/overview?symbol=RAI&#038;inline=nyt-org" class="tickerized" title="More information about Reynolds American Inc">Reynolds American</a> is seeking to buy a rival tobacco company, Lorillard, for $27.4 billion, and <a href="//dealbook.on.nytimes.com/public/overview?symbol=FB&#038;inline=nyt-org" class="tickerized" title="More information about Facebook, Inc.">Facebook</a> acquired WhatsApp for $21.8 billion.</p>
<p class="story-body-text" itemprop="articleBody">Facebook, like many other big companies, paid for its acquisitions largely with its own stock, which has risen along with the broader market this year. Those companies that needed to borrow billions to pay for costly acquisitions were emboldened by interest rates, which remain near record lows and show no signs of rising soon.</p>
<p class="story-body-text" itemprop="articleBody">Another factor fueling deal making this year has been <a href="//dealbook.nytimes.com/2014/11/17/the-luck-of-a-loser-to-the-tune-of-2-2-billion/" title="Sorkin:  The Luck of a Loser, to the Tune of $2.2 Billion">the presence of activist hedge funds</a>. William A. Ackmanâs hedge fund Pershing Square Capital Management had been working with another company, <a href="//dealbook.on.nytimes.com/public/overview?symbol=VRX&#038;inline=nyt-org" class="tickerized" title="More information about Valeant Pharmaceuticals International Inc">Valeant</a>, in an effort to buy Allergan, putting the Botox maker in play for its eventual sale to Actavis. And <a href="//topics.nytimes.com/top/reference/timestopics/people/i/carl_c_icahn/index.html?inline=nyt-per" class="tickerized" title="More articles about Carl C. Icahn.">Carl C. Icahn</a> has successfully agitated for the sale of a number of companies, including <a href="//dealbook.on.nytimes.com/public/overview?symbol=FDO&#038;inline=nyt-org" class="tickerized" title="More information about Family Dollar Stores Inc">Family Dollar</a>.</p>
<p class="story-body-text" itemprop="articleBody">The previous two merger booms preceded sharp economic downturns. The dot-com bubble burst in 2001, and the leveraged buyout surge was scuttled by the financial crisis. But this time, bankers are not bracing for another downturn.</p>
<p class="story-body-text" itemprop="articleBody">âThe buildup here has been more disciplined, longer and more methodical, which hopefully means that it will continue,â said Blair W. Effron, co-founder of Centerview Partners, an independent investment bank that has advised on many of the yearâs big deals.</p>
<p class="story-body-text" itemprop="articleBody">Yet more than anything, it is the sense of relative stability that has unleashed Wall Streetâs deal makers. And until that changes â in the form of a stock market crash or another debt crisis â the merger boom seems likely to continue.</p>
<p class="story-body-text" itemprop="articleBody">âThis is another consistent piece of information that the economy really is doing well right now,â Ms. Sinclair, the economics professor, said. âBut thereâs also reason to be slightly concerned. When you see a bunch of deals all at once, you wonder that if this is, once again, irrational exuberance.â </p>
			<div class="nyt-article-promo">
								<div class="w190">
					<a href="//dealbook.nytimes.com/2014/11/17/allergan-agrees-to-be-sold-to-actavis/?ref=dealbook"><img src="https://static01.nyt.com/images/2014/11/18/business/Drugjp/Drugjp-thumbWide.jpg" width="190" height="126" alt="Allergan Escapes Valeantâs Pursuit, Agreeing to Be Bought by Actavis" /></a>
				</div>
                				<h4><a href="//dealbook.nytimes.com/2014/11/17/allergan-agrees-to-be-sold-to-actavis/?ref=dealbook">Allergan Escapes Valeantâs Pursuit, Agreeing to Be Bought by Actavis</a></h4>
				<p class="nyt-article-byline">By DAVID GELLES</p>
				<p class="nyt-article-summary">The $66 billion acquisition by Actavis would be the largest deal this year and would thwart the takeover effort of Valeant and William A. Ackman.</p>
			</div>
			
			<div class="nyt-article-promo">
								<div class="w190">
					<a href="//www.nytimes.com/interactive/2014/11/18/business/dealbook/18allergan-timeline.html?ref=dealbook"><img src="https://static01.nyt.com/images/2014/11/18/business/18TIMELINE1/18TIMELINE1-thumbWide.jpg" width="190" height="126" alt="Timeline: A Rocky Path to Allerganâs Deal" /></a>
				</div>
                				<h4><a href="//www.nytimes.com/interactive/2014/11/18/business/dealbook/18allergan-timeline.html?ref=dealbook">Timeline: A Rocky Path to Allerganâs Deal</a></h4>
				<p class="nyt-article-byline"></p>
				<p class="nyt-article-summary">A timeline of the events that led to Allerganâs agreement to be acquired by Actavis in the face of a hostile takeover.</p>
			</div>
			
			<div class="nyt-article-promo">
								<div class="w190">
					<a href="//dealbook.nytimes.com/2014/11/17/the-luck-of-a-loser-to-the-tune-of-2-2-billion/?ref=dealbook"><img src="https://static01.nyt.com/images/2014/11/18/business/Sorkin/Sorkin-thumbWide.jpg" width="190" height="126" alt="Ackman Has Luck of a Loser, to the Tune of $2.2 Billion" /></a>
				</div>
                				<h4><a href="//dealbook.nytimes.com/2014/11/17/the-luck-of-a-loser-to-the-tune-of-2-2-billion/?ref=dealbook">Ackman Has Luck of a Loser, to the Tune of $2.2 Billion</a></h4>
				<p class="nyt-article-byline">By ANDREW ROSS SORKIN</p>
				<p class="nyt-article-summary">William A. Ackman and Valeant Pharmaceuticals lost their hostile battle to buy Allergan and still came away with a total of $2.6 billion.</p>
			</div>
			
			<div class="nyt-article-promo">
								<div class="w190">
					<a href="//dealbook.nytimes.com/2014/11/17/halliburton-to-buy-baker-hughes-for-34-billion/?ref=dealbook"><img src="https://static01.nyt.com/images/2014/11/18/business/dbpix-baker1/dbpix-baker1-thumbWide.jpg" width="190" height="126" alt="Halliburton and Baker Hughes Agree to Friendly $34.6 Billion Merger" /></a>
				</div>
                				<h4><a href="//dealbook.nytimes.com/2014/11/17/halliburton-to-buy-baker-hughes-for-34-billion/?ref=dealbook">Halliburton and Baker Hughes Agree to Friendly $34.6 Billion Merger</a></h4>
				<p class="nyt-article-byline">By MICHAEL J. DE LA MERCED</p>
				<p class="nyt-article-summary">Together, the two are expected to save nearly $2 billion in costs through a combination of operations and research and development.</p>
			</div>
			
<footer class="story-footer">
    <div class="story-meta">
	<p class="story-print-citation">A version of this article appears in print on 11/18/2014, on page <span itemprop="printSection">A</span><span itemprop="printPage">1</span> of the <span itemprop="printEdition">NewYork</span> edition with the headline: Mega-Mergers Popular Again on Wall Street.</p>    </div>
</footer>
	</div>
		<footer class="entry-footer">
			<button class="button comments-button theme-speech-bubble"></button>		<div id="sharetools-post-footer" class="sharetools theme-classic" data-shares="show-all|Share" data-url="https://dealbook.nytimes.com/2014/11/17/mega-mergers-popular-again-on-wall-street/" data-title="Mega-Mergers Popular Again on Wall Street" data-description="A pair of deals announced on Monday, worth $100 billion, brought the yearâs total for American companies to $1.5 trillion, the highest since 2000. ">
				<div class="ad sharetools-inline-article-ad hidden"></div>
			</div>		<div class="footer-tags">
					</div>
		</footer>
</article>
		<section id="whats-next" class="whats-next nocontent robots-nocontent">
    <h2 class="visually-hidden">What's Next</h2>
    <div class="nocontent robots-nocontent">
        <div class="loader-container">
            <div class="loader loader-t-logo-32x32-ecedeb-ffffff"><span class="visually-hidden">Loading...</span></div>
        </div>
    </div><!-- close nocontent -->
</section>

			</div><!-- end content -->
</div><!-- end .a-column -->
<div class="cColumn nocontent robots-nocontent">
	<aside>
	<div class="postNavigation">
	<ul class="opposingFloatControl wrap">
		<li class="element1">
						<span class="previous">Previous Post</span>
			<div class="arrow arrow-left">
				<div class="arrow-conceal"></div>
			</div>
			<a class="postTitle" href="https://dealbook.nytimes.com/2014/11/17/the-luck-of-a-loser-to-the-tune-of-2-2-billion/" title="Ackman Has Luck of a Loser, to the Tune of $2.2 Billion">
				Ackman Has Luck of a Loser, to the Tune of $2.2 Billion			</a>
					</li>
		<li class="element2">
						<span class="next">Next Post</span>
			<div class="arrow arrow-right">
				<div class="arrow-conceal"></div>
			</div>
			<a class="postTitle" href="https://dealbook.nytimes.com/2014/11/18/morning-agenda-return-of-the-mega-merger/" title="Morning Agenda: Return of the Mega-Merger">
				Morning Agenda: Return of the Mega-Merger			</a>
					</li>
	</ul>
</div>
		<div class="module ad" id="MiddleRight"></div>
        	</aside>
</div>		<div class="clear"></div>
	</div><!-- end blog wrap -->
	<div class="hideContent"></div>

	
<!-- Google Analytics start -->
<script type="text/javascript">
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;if (!/NYT-T=out/.test(document.cookie)) {m.parentNode.insertBefore(a,m)} })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-4406282-12',  { 'alwaysSendReferrer': true } );
ga('send', 'pageview');
</script>
<!-- Google Analytics end -->
		<div id="mobilebanner2" class="ad mobilebanner2"></div>
		<div class="accessibility-ad-header visually-hidden">
    <p>Advertisement</p>
</div>
<div id="SponLink" class="text-ad bottom-left-ad nocontent robots-nocontent"></div>

		<div id="Top5" class="ad top5-ad hidden nocontent robots-nocontent"></div>

					</div>
			<div class="search-overlay"></div>
		</main><!-- close main -->
						<footer id="page-footer" class="page-footer" role="contentinfo">
    <nav>
         <ul>
             <li>
                <a href="https://www.nytco.com" itemprop="copyrightNotice">
                    &copy; <span itemprop="copyrightYear">2017</span>
					<span itemprop="copyrightHolder provider sourceOrganization" itemscope
						itemtype="//schema.org/Organization"
						itemid="//www.nytimes.com">
						<span itemprop="name"> The New York Times Company</span>
						<meta itemprop="tickerSymbol" content="NYSE NYT"/>
					</span>
                </a>
            </li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/infoservdirectory.html">Contact Us</a></li>
            <li><a href="//www.nytco.com/careers/">Work With Us</a></li>
            <li><a href="//nytmediakit.com/">Advertise</a></li>
            <li><a href="https://www.nytimes.com/content/help/rights/privacy/policy/privacy-policy.html#pp">Your Ad Choices</a></li>
            <li><a href="https://www.nytimes.com/privacy">Privacy</a></li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/agree.html" itemprop="usageTerms">Terms of Service</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/content/help/rights/sale/terms-of-sale.html">Terms of Sale</a></li>
         </ul>
    </nav>
    <nav class="last-nav">
        <ul>
            <li><a href="//spiderbites.nytimes.com">Site Map</a></li>
            <li><a href="https://www.nytimes.com/membercenter/sitehelp.html">Help</a></li>
            <li><a href="https://myaccount.nytimes.com/membercenter/feedback.html">Site Feedback</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/subscriptions/Multiproduct/lp5558.html?campaignId=37WXW">Subscriptions</a></li>
        </ul>
    </nav>
</footer>		</div><!-- close shell -->
	<script>
require(['foundation/main'], function () {
    require(['blogs/main']);
    require(['jquery/nyt', 'foundation/views/page-manager'], function ($, pageManager) {
        if (window.location.search.indexOf('disable_tagx') > 0) {
            return;
        }
        $(document).ready(function () {
            require(['https://a1.nyt.com/analytics/json-kidd.min.js'], function () {
                pageManager.trackingFireEventQueue();
            });
        });
    });
});
</script>

	<div id="Inv1" class="ad inv1-ad hidden"></div>
<div id="Inv2" class="ad inv2-ad hidden"></div>
<div id="Inv3" class="ad inv3-ad hidden"></div>
<div id="ab1" class="ad ab1-ad hidden"></div>
<div id="ab2" class="ad ab2-ad hidden"></div>
<div id="ab3" class="ad ab3-ad hidden"></div>
<div id="prop1" class="ad prop1-ad hidden"></div>
<div id="prop2" class="ad prop2-ad hidden"></div>
<div id="Anchor" class="ad anchor-ad hidden"></div>
<div id="ADX_CLIENTSIDE" class="ad adx-clientside-ad hidden"></div>
		<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"b5bcf2eba4","applicationID":"5164608","transactionName":"YwFXZhRYVhAEVUZcX1pLYEAPFlkTFRtQWV9TFxtCDkk=","queueTime":0,"applicationTime":84,"ttGuid":"","agentToken":"","userAttributes":"","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
